Table 1 Patient characteristics of the study population with respect to treatment
NACa | NoNACb | All | |
|---|---|---|---|
Patients, n (%) | 82 (14%) | 493 (86%) | 575 (100%) |
Age, median (IQR) | 65 (56,68) | 70 (63,76) | 69 (62,75) |
Females, n (%) | 24 (29%) | 100 (20%) | 124 (22%) |
Academic hospital, n (%) | 62 (76%) | 299 (61%) | 361 (63%) |
Health region, n (%) | |||
Southeast | 40 (49%) | 274 (56%) | 314 (55%) |
West | 22 (27%) | 99 (20%) | 121 (21%) |
Central | 11 (13%) | 57 (12%) | 68 (12%) |
North | 9 (11%) | 63 (13%) | 72 (13%) |
Cystectomy year, n (%) | |||
2008–2009 | 16 (20%) | 172 (35%) | 188 (33%) |
2010–2011 | 9 (11%) | 211 (43%) | 220 (38%) |
2012–2015 | 57 (70%) | 110 (22%) | 167 (29%) |
Number of deaths, n (%) | 47 (57%) | 301 (61%) | 348 (60%) |
Cause of death, n (%) | |||
Bladder cancer | 37 (45%) | 204 (41%) | 241 (42%) |
Other causes | 10 (12%) | 97 (20%) | 107 (19%) |